Aurinia Pharmaceuticals Inc
$8.65
(as of Jun 27, 2:35 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Aurinia Pharmaceuticals Inc
Stock Price
$8.65
Ticker Symbol
AUPH
Exchange
NASDAQ
Industry Information for Aurinia Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Fundamentals for Aurinia Pharmaceuticals Inc
Market Capitalization
$1,084,885,120
EBITDA
$61,923,000
Dividends per Share
P/E Ratio
29.74
Forward P/E Ratio
14.12
Earnings per Share
$0.27
Earnings per Share Estimate Next Year
Profit Margin
16.11%
Shares Outstanding
135,104,000
Percent Owned by Insiders
9.84%
Percent Owned by Institutions
47.38%
52-Week High
52-Week Low
Technical Indicators for Aurinia Pharmaceuticals Inc
Analyst Ratings for Aurinia Pharmaceuticals Inc
Strong Buy
3
Buy
2
Hold
1
Sell
0
Strong Sell
0
News About Aurinia Pharmaceuticals Inc
Jun 17, 2025, 4:43 PM EST
In trading on Tuesday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed below their 200 day moving average of $7.96, changing hands as low as $7.91 per share. See more.
May 13, 2025, 9:24 AM EST
Shares of NRG Energy, Inc. See more.
Apr 2, 2025, 6:37 AM EST
Aurinia Pharmaceuticals (NASDAQ:AUPH) has had a rough three months with its share price down 10%. See more.
Mar 25, 2025, 10:41 AM EST
We recently published a list of Insiders Are Spending Big: 15 Stocks Leading in March. See more.